← All insiders

MEDP

Medpace Holdings, Inc.

28 transactions on file, per SEC Form 4 filings.

See MEDP superinvestor activity →

Troendle August J.

President & CEO · 2026-08-27

Sold

$403K

Kraft Robert O.

director · 2026-08-26

Option exercise

$325K

Kraft Robert O.

director · 2026-08-26

Sold

$2.4M

Troendle August J.

President & CEO · 2026-08-26

Sold

$2.5M

Troendle August J.

President & CEO · 2026-08-25

Sold

$418K

Troendle August J.

President & CEO · 2026-08-24

Sold

$1.2M

Troendle August J.

President & CEO · 2026-08-21

Sold

$8.7M

Brady Kevin M.

CFO & Treasurer · 2026-08-20

Option exercise

$472K

Brady Kevin M.

CFO & Treasurer · 2026-08-20

Sold

$2.1M

Troendle August J.

President & CEO · 2026-08-20

Sold

$16.8M

Troendle August J.

President & CEO · 2026-08-19

Sold

$9.5M

Carley Brian T

director · 2026-08-19

Sold

$3.0M

DAVENPORT FRED B JR

director · 2026-08-19

Option exercise

$300K

DAVENPORT FRED B JR

director · 2026-08-19

Option exercise

$325K

DAVENPORT FRED B JR

director · 2026-08-19

Option exercise

$255K

DAVENPORT FRED B JR

director · 2026-08-19

Sold

$4.4M

Troendle August J.

President & CEO · 2026-08-13

Sold

$275K

Troendle August J.

President & CEO · 2026-08-12

Sold

$6.8M

McCarthy Cornelius P. III

director · 2026-08-11

Sold

$690K

Troendle August J.

President & CEO · 2026-08-11

Sold

$10.7M

Troendle August J.

President & CEO · 2026-08-10

Sold

$3.3M

McCarthy Cornelius P. III

director · 2026-08-07

Option exercise

$325K

McCarthy Cornelius P. III

director · 2026-08-07

Sold

$465K

Troendle August J.

President & CEO · 2026-07-28

Sold

$2.1M

BURWIG SUSAN E

Exec. VP, Operations · 2026-07-28

Sold

$4.5M

Troendle August J.

President & CEO · 2026-07-27

Sold

$2.2M

McCarthy Cornelius P. III

director · 2026-06-30

Option exercise

28 sh

Carley Brian T

director · 2026-06-30

Option exercise

36 sh

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is MEDP actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.

Analyze MEDP